Citation

Chanen AM, Thompson KN. Aust. Prescr. 2016; 39(2): 49-53.

Copyright

(Copyright © 2016, National Prescribing Service (Australia))

DOI

10.18773/austprescr.2016.019

PMID

unavailable

Abstract

Accurate diagnosis is fundamental to effective management of borderline personality disorder, but many patients remain undetected. The first-line management for borderline personality disorder is psychosocial treatment, not drugs. There are major prescribing hazards including polypharmacy, overdose and misuse. Drug treatment might be warranted for patients who have a co-occurring mental disorder such as major depression. If a drug is prescribed for borderline personality disorder, it should only be as an adjunct to psychosocial treatment. There should be clear and collaborative goals that are regularly reviewed with the patient. Use single drugs prescribed in limited quantities for a limited time. Stop drugs that are ineffective. © 2016 Australian Government Publishing Service. All Rights Reserved.

Language: en

Keywords

human; suicide; psychotherapy; Borderline personality disorder; comorbidity; disease severity; mood disorder; Polypharmacy; Antidepressant; prescription; clinical feature; human relation; quetiapine; behavior therapy; cognitive therapy; paranoia; impulsiveness; self concept; psychotropic agent; practice guideline; doctor patient relation; medical society; psychosocial care; borderline state; olanzapine; valproic acid; lamotrigine; topiramate; evidence based medicine; omega 3 fatty acid; aripiprazole; mood stabilizer; Article; randomized controlled trial (topic); DSM-5; psychological and psychiatric procedures; Anti-psychotic agent; Psychosocial intervention strategy